story of the week
CCNE1 and PLK1 Mediates Resistance to Palbociclib in Patients With HR+/HER2− Metastatic Breast Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CCNE1 and PLK1 mediates resistance to palbociclib in HR+/HER2- metastatic breast cancer
Clin. Cancer Res 2023 Feb 07;[EPub Ahead of Print], Á Guerrero-Zotano, S Belli, C Zielinski, M Gil-Gil, A Fernandez-Serra, M Ruiz-Borrego, EM Ciruelos Gil, J Pascual, M Muñoz-Mateu, B Bermejo, M Margeli Vila, A Antón, L Murillo, B Nisenbaum, Y Liu, J Herranz, D Fernandez Garcia, R Caballero, JA López-Guerrero, R Bianco, L Formisano, N Turner, M MartínFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.